ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 191 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $5,000 | +66.7% | 200 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $3,000 | -25.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $4,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $4,000 | -33.3% | 200 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $6,000 | -86.7% | 200 | -83.3% | 0.00% | -88.9% |
| Q3 2017 | $45,000 | +36.4% | 1,200 | 0.0% | 0.03% | +28.6% |
| Q2 2017 | $33,000 | -99.9% | 1,200 | 0.0% | 0.02% | -19.2% |
| Q1 2017 | $41,256,000 | – | 1,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |